How Pfizer Profited From the Pandemic
The COVID-19 pandemic has given the drugmaker unique weight in determining US health policy. How can the American people push back against this?
STORY AT-A-GLANCE
The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, it has also given the drugmaker unique weight in determining U.S. health policy — something that concerns even staunch vaccine-pushers like Dr. Paul Offit
Pfizer’s revenue in 2021 was $81.3 billion — approximately double that of 2020 — …
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.